High- and Low-risk Actinic Keratosis Referrals to Secondary Care

Trial Title: High- and Low-risk Actinic Keratosis Referrals to Secondary Care

NCT ID: NCT05976061

Condition: Actinic Keratoses

Conditions: Official terms:
Keratosis, Actinic
Keratosis

Conditions: Keywords:
General Practitioners guidelines
actinic keratosis
general physician
dermatology
low-risk patients
referrals

Study type: Observational

Overall status: Active, not recruiting

Study design:

Time perspective: Retrospective

Summary: This study evaluates the implementation of the General Practitioners guidelines 'Suspicious Skin Lesions' and investigated whether their publication and implementation has led to a reduction in the proportion of referrals of low-risk patients with actinic keratosis to secondary care, after publication of the General Practitioners guidelines and implementation activities.

Detailed description: In the Dutch healthcare system, patients are first examined by the general practitioner who decides whether a referral to a dermatologist is indicated. Both general practitioners and dermatologists can diagnose and treat patients with actinic keratosis. Therefore, it is necessary to distinguish which patients the general practitioner should refer to a dermatologist and which patients are suitable to be treated by the general practitioner. This retrospective data study evaluates the proportion of low risk actinic keratosis patients in 2019 en 2018.

Criteria for eligibility:

Study pop:
Data from patients are collected retrospectively using the Electronic health records. Patients were selected based on the diagnosis-treatment-combination (DTC) 17 (premalignant lesion) and DTC 14 (cutaneous malignancy) that was registered from January 2018 to December 2019 by the dermatologist.

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - patients of 18 years and older - referred to dermatologist for suspicion of actinic keratosis and diagnosed as actinic keratosis by the dermatologist - treated at MaastrichtUMC+ or TergooiHospital Exclusion Criteria: - different diagnosis than actinic keratosis - referred by a different specialist than the general practitioner - referred with multiple problems - referred for a second opinion - if the patients was treated as different diagnosis than actinic keratosis by general practitioner

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Ellen Oyen

Address:
City: Maastricht
Country: Netherlands

Start date: March 1, 2021

Completion date: December 1, 2024

Lead sponsor:
Agency: Maastricht University Medical Center
Agency class: Other

Collaborator:
Agency: Tergooi Hospital
Agency class: Other

Source: Maastricht University Medical Center

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05976061
https://richtlijnen.nhg.org/standaarden/verdachte-huidafwijkingen